HER2 Breast Cancer

Latest News

3D visualization of breast cancer cell metastasis | Image Credit: © freshidea - stock.adobe.com
Pyrotinib-Based Therapy May Improve Survival in Patients With HER2+ Breast Cancer and Liver Metastases

April 25th 2025

Pyrotinib is a tyrosine kinase inhibitor that is independently developed in China.

3D visualization of cancer cells | Image Credit: © Best - stock.adobe.com
Ribociclib With Nonsteroidal Aromatase Inhibitor Does Not Reduce Quality of Life in HR+/HER2- Early Breast Cancer

April 24th 2025

3D illustration of trastuzumab molecule | Image Credit: © LASZLO - stock.adobe.com
Study Links PAK5 to Poor Outcomes and Drug Resistance in HER2-Positive Breast Cancer

April 23rd 2025

3D rendering of antibody drug conjugates | Image Credit: © Alpha Tauri 3D - stock.adobe.com
Trastuzumab Deruxtecan Plus Pertuzumab Improves Progression-Free Survival in Patients With HER2+ Metastatic Breast Cancer

April 21st 2025

Concept image of an antibody drug conjugate | Image Credit: © AddMeshCube - stock.adobe.com
Real-World Data Show Improved Survival With Sacituzumab Govitecan as First-Line ADC in HER2-Low Breast Cancer

April 18th 2025

<123456